You are here

Article info

Article menu

Download PDFPDF

XML
Commentary
Changing TACTICS in intermediate HCC: TACE plus sorafenib

Authors

  • Pompilia Radu University Clinic for Visceral Surgery and Medicine, University of Bern, Inselspital, Bern, Switzerland PubMed articlesGoogle scholar articles
  • Jean-François Dufour University Clinic for Visceral Surgery and Medicine, University of Bern, Inselspital, Bern, Switzerland Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jean-François Dufour, Hepatology, Department of Clinical Research, University of Bern, Bern 3010, Switzerland; jean-francois.dufour{at}dbmr.unibe.ch
View Full Text

Citation

Radu P, Dufour J
Changing TACTICS in intermediate HCC: TACE plus sorafenib
Gut 2020;69:1374-1376.

Publication history

  • Received January 16, 2020
  • Revised February 24, 2020
  • Accepted February 24, 2020
  • First published March 13, 2020.
Online issue publication 
August 19, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.